Although all these preliminary studies were performed with a limited number of patient samples, our findings agree with these reports, demonstrating robust production of the neutrophil-chemoattractant chemokine CXCL8 as a universal COVID-19 mediator in systemic and airway compartments. The gene discussed is CXCL8; the disease is COVID-19.